NTRK CONNECT - Experts Knowledge Share

Wednesday, January 20th 2021
JST (+1 Day)

About This Meeting

Current opinions on how to identify, test and treat NTRK fusion positive cancer. Learn about and discuss: -

  • Treating NTRK fusion cancer today and in the future
  • Testing methodologies and tumour-specific algorithms
  • Adverse events associated with TRK inhibitors

Meeting Materials

To view meeting materials, you need to be registered for the meeting.


Prof. David Hong
University of Texas MD Anderson Cancer Center
Houston, USA
Prof. Frédérique Penault-Llorca
University of Clermont-Auvergne
Prof. Ezra Cohen
UC San Diego Health-Moores Cancer Center
California, USA
This content is supported by an Independent Educational Grant from Bayer

COR2ED develops and implements high quality Independent Medical Education programmes to help improve the health of patients globally.
Bodenackerstrasse 17
4103 Bottmingen
Disclaimer: The material and content contained in the website COR2EDEngage.com is for healthcare professionals only. Although every effort is made to ensure that the material within this website is accurate and timely, it is provided for informational and educational purposes only. The information provided is not intended as a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country.
© Copyright 2021 | All Rights Reserved 
Website design & maintenance by Zesty Digital
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.